(*) USA Approval Date: 2022. 02.17
>Deficiency>Treat.>PK Activator Tab
Company
Generic Name: Mitapivat
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2022. 02.15.
PK: Pyruvate Kinase
RTM
RTM Web-Site